HEADER HYDROLASE 14-NOV-03 1RHJ TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-3; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: P17 SUBUNIT; COMPND 5 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN, COMPND 6 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 7 EC: 3.4.22.-; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: CASPASE-3; COMPND 11 CHAIN: B, D; COMPND 12 FRAGMENT: P12 SUBUNIT; COMPND 13 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN, COMPND 14 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1; COMPND 15 EC: 3.4.22.-; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP3, CPP32; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET20B+; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: CASP3, CPP32; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, COMPLEX KEYWDS 2 (PROTEASE-INHIBITOR), HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.W.BECKER,J.ROTONDA,S.M.SOISSON REVDAT 3 11-OCT-17 1RHJ 1 REMARK REVDAT 2 24-FEB-09 1RHJ 1 VERSN REVDAT 1 11-MAY-04 1RHJ 0 JRNL AUTH J.W.BECKER,J.ROTONDA,S.M.SOISSON,R.ASPIOTIS,C.BAYLY, JRNL AUTH 2 S.FRANCOEUR,M.GALLANT,M.GARCIA-CALVO,A.GIROUX,E.GRIMM,Y.HAN, JRNL AUTH 3 D.MCKAY,D.W.NICHOLSON,E.PETERSON,J.RENAUD,S.ROY, JRNL AUTH 4 N.THORNBERRY,R.ZAMBONI JRNL TITL REDUCING THE PEPTIDYL FEATURES OF CASPASE-3 INHIBITORS: A JRNL TITL 2 STRUCTURAL ANALYSIS. JRNL REF J.MED.CHEM. V. 47 2466 2004 JRNL REFN ISSN 0022-2623 JRNL PMID 15115390 JRNL DOI 10.1021/JM0305523 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 175071.300 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.1 REMARK 3 NUMBER OF REFLECTIONS : 29784 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.252 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2987 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 29784 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4086 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE : 0.2850 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 469 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3740 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 233 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.58000 REMARK 3 B22 (A**2) : 3.84000 REMARK 3 B33 (A**2) : -4.42000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -3.76000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.18 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.320 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.070 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.220 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.200 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 40.66 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : PYR.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : PYR.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1RHJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-NOV-03. REMARK 100 THE DEPOSITION ID IS D_1000020749. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30288 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 19.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.6 REMARK 200 DATA REDUNDANCY : 3.360 REMARK 200 R MERGE (I) : 0.05600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 76.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.41 REMARK 200 R MERGE FOR SHELL (I) : 0.16400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: PROTEIN PART OF 1PAU.PDB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.66 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG-6000, 100 MM CITRATE, 20 MM L REMARK 280 -CYSTEINE, 5 MM GLYCEROL, 3 MM NAN(3), PH 4.8, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.38200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -71.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 145 REMARK 465 GLY A 146 REMARK 465 ILE A 147 REMARK 465 SER A 148 REMARK 465 LEU A 149 REMARK 465 THR A 296 REMARK 465 ASP A 297 REMARK 465 SER B 310 REMARK 465 GLY B 311 REMARK 465 VAL B 312 REMARK 465 ASP B 313 REMARK 465 ASP B 314 REMARK 465 ASP B 315 REMARK 465 MET B 316 REMARK 465 ALA B 317 REMARK 465 CYS B 318 REMARK 465 HIS B 319 REMARK 465 HIS B 402 REMARK 465 LEU B 403 REMARK 465 GLU B 404 REMARK 465 HIS B 405 REMARK 465 HIS B 406 REMARK 465 HIS B 407 REMARK 465 HIS B 408 REMARK 465 HIS B 409 REMARK 465 HIS B 410 REMARK 465 SER C 645 REMARK 465 GLY C 646 REMARK 465 ILE C 647 REMARK 465 SER C 648 REMARK 465 LEU C 649 REMARK 465 THR C 796 REMARK 465 ASP C 797 REMARK 465 SER D 810 REMARK 465 GLY D 811 REMARK 465 VAL D 812 REMARK 465 ASP D 813 REMARK 465 ASP D 814 REMARK 465 ASP D 815 REMARK 465 MET D 816 REMARK 465 ALA D 817 REMARK 465 CYS D 818 REMARK 465 HIS D 819 REMARK 465 HIS D 902 REMARK 465 LEU D 903 REMARK 465 GLU D 904 REMARK 465 HIS D 905 REMARK 465 HIS D 906 REMARK 465 HIS D 907 REMARK 465 HIS D 908 REMARK 465 HIS D 909 REMARK 465 HIS D 910 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 175A -1.66 -58.09 REMARK 500 LYS A 197 30.85 78.59 REMARK 500 ASP A 205 73.49 35.98 REMARK 500 SER A 236 -170.27 -175.07 REMARK 500 CYS A 270 79.46 -119.97 REMARK 500 LYS B 363 -58.21 -130.85 REMARK 500 PHE B 400 30.87 -84.23 REMARK 500 LYS C 697 32.34 72.22 REMARK 500 ASP C 705 75.67 42.63 REMARK 500 SER C 736 -170.78 -178.38 REMARK 500 ASP D 826 32.98 74.27 REMARK 500 LYS D 863 -46.64 -145.08 REMARK 500 PHE D 900 30.07 -84.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZN C 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PZN A 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PAU RELATED DB: PDB REMARK 900 CASPASE-3 COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-ALDEHYDE REMARK 900 RELATED ID: 1RHK RELATED DB: PDB REMARK 900 RELATED ID: 1RHM RELATED DB: PDB REMARK 900 RELATED ID: 1RHQ RELATED DB: PDB REMARK 900 RELATED ID: 1RHR RELATED DB: PDB REMARK 900 RELATED ID: 1RHU RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE HIS TAGS ON CHAINS B AND D WERE NOT REMARK 999 CLEAVED FOR THIS ENTRY. DBREF 1RHJ A 145 297 UNP P42574 CASP3_HUMAN 29 175 DBREF 1RHJ B 310 402 UNP P42574 CASP3_HUMAN 176 277 DBREF 1RHJ C 645 797 UNP P42574 CASP3_HUMAN 29 175 DBREF 1RHJ D 810 902 UNP P42574 CASP3_HUMAN 176 277 SEQADV 1RHJ GLU B 324 UNP P42574 ASP 190 ISOFORM BETA SEQADV 1RHJ LEU B 403 UNP P42574 EXPRESSION TAG SEQADV 1RHJ GLU B 404 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 405 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 406 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 407 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 408 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 409 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS B 410 UNP P42574 EXPRESSION TAG SEQADV 1RHJ GLU D 824 UNP P42574 ASP 190 ISOFORM BETA SEQADV 1RHJ LEU D 903 UNP P42574 EXPRESSION TAG SEQADV 1RHJ GLU D 904 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 905 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 906 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 907 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 908 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 909 UNP P42574 EXPRESSION TAG SEQADV 1RHJ HIS D 910 UNP P42574 EXPRESSION TAG SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 A 147 ILE GLU THR ASP SEQRES 1 B 110 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 B 110 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 B 110 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 B 110 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 B 110 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 B 110 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 B 110 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 B 110 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS LEU GLU SEQRES 9 B 110 HIS HIS HIS HIS HIS HIS SEQRES 1 C 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR SEQRES 2 C 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN SEQRES 3 C 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR SEQRES 4 C 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN SEQRES 5 C 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG SEQRES 6 C 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU SEQRES 7 C 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU SEQRES 8 C 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY SEQRES 9 C 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY SEQRES 10 C 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE SEQRES 11 C 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY SEQRES 12 C 147 ILE GLU THR ASP SEQRES 1 D 110 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO SEQRES 2 D 110 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO SEQRES 3 D 110 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP SEQRES 4 D 110 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA SEQRES 5 D 110 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN SEQRES 6 D 110 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP SEQRES 7 D 110 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL SEQRES 8 D 110 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS LEU GLU SEQRES 9 D 110 HIS HIS HIS HIS HIS HIS HET PZN A 501 41 HET PZN C 502 41 HETNAM PZN 3-(2-{5-TERT-BUTYL-3-[(4-METHYL-FURAZAN-3-YLMETHYL)- HETNAM 2 PZN AMINO]-2-OXO-2H-PYRAZIN-1-YL}-BUTYRYLAMINO)-5-(HEXYL- HETNAM 3 PZN METHYL-AMINO)-4-OXO-PENTANOIC ACID ANION FORMUL 5 PZN 2(C28 H44 N7 O6 1-) FORMUL 7 HOH *233(H2 O) HELIX 1 1 HIS A 174 GLY A 175C 5 5 HELIX 2 2 GLY A 181 LEU A 196 1 16 HELIX 3 3 THR A 207 LYS A 220 1 14 HELIX 4 4 LEU A 258 PHE A 264 1 7 HELIX 5 5 CYS A 270 THR A 274 5 5 HELIX 6 6 TRP B 348 ALA B 361 1 14 HELIX 7 7 GLU B 365 PHE B 380 1 17 HELIX 8 8 ASP B 381E HIS B 381I 5 5 HELIX 9 9 HIS C 674 GLY C 675C 5 5 HELIX 10 10 GLY C 681 LEU C 696 1 16 HELIX 11 11 THR C 707 GLU C 721 1 15 HELIX 12 12 LEU C 758 PHE C 764 1 7 HELIX 13 13 CYS C 770 THR C 774 5 5 HELIX 14 14 TRP D 848 ALA D 861 1 14 HELIX 15 15 GLU D 865 PHE D 880 1 17 HELIX 16 16 ASP D 881E HIS D 881I 5 5 SHEET 1 A12 GLU A 199 ASN A 204 0 SHEET 2 A12 GLU A 162 ASN A 169 1 N ILE A 167 O ARG A 201 SHEET 3 A12 ARG A 227 LEU A 235 1 O VAL A 233 N ILE A 166 SHEET 4 A12 LYS A 278 GLN A 283 1 O LEU A 279 N PHE A 230 SHEET 5 A12 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280 SHEET 6 A12 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329 SHEET 7 A12 CYS D 888 MET D 893 -1 O SER D 892 N ILE B 389 SHEET 8 A12 PHE D 827 TYR D 831 -1 N TYR D 829 O VAL D 890 SHEET 9 A12 LYS C 778 GLN C 783 1 N PHE C 780 O LEU D 828 SHEET 10 A12 ARG C 727 LEU C 735 1 N PHE C 730 O LEU C 779 SHEET 11 A12 GLU C 662 ASN C 669 1 N ILE C 666 O VAL C 733 SHEET 12 A12 GLU C 699 ASN C 704 1 O LYS C 703 N ASN C 669 SHEET 1 B 3 GLY A 238 GLU A 239 0 SHEET 2 B 3 ILE A 242 GLY A 245 -1 O ILE A 242 N GLU A 239 SHEET 3 B 3 GLY A 254 ASP A 257 -1 O GLY A 254 N GLY A 245 SHEET 1 C 2 ARG B 341 ASN B 342 0 SHEET 2 C 2 GLY B 346 SER B 347 -1 O GLY B 346 N ASN B 342 SHEET 1 D 3 GLY C 738 GLU C 739 0 SHEET 2 D 3 ILE C 742 GLY C 745 -1 O ILE C 742 N GLU C 739 SHEET 3 D 3 GLY C 754 ASP C 757 -1 O GLY C 754 N GLY C 745 SHEET 1 E 2 ARG D 841 ASN D 842 0 SHEET 2 E 2 GLY D 846 SER D 847 -1 O GLY D 846 N ASN D 842 LINK SG CYS A 285 C9 PZN A 501 1555 1555 1.85 LINK SG CYS C 785 C9 PZN C 502 1555 1555 1.85 SITE 1 AC1 13 HOH C 190 ARG C 679 SER C 736 HIS C 737 SITE 2 AC1 13 GLY C 738 GLN C 783 CYS C 785 TYR D 838 SITE 3 AC1 13 SER D 839 TRP D 840 ARG D 841 SER D 881A SITE 4 AC1 13 PHE D 881B SITE 1 AC2 15 ARG A 179 HIS A 237 GLY A 238 GLN A 283 SITE 2 AC2 15 ALA A 284 CYS A 285 HOH A 519 HOH A 524 SITE 3 AC2 15 TYR B 338 SER B 339 TRP B 340 ARG B 341 SITE 4 AC2 15 SER B 381A PHE B 381B PHE B 381H CRYST1 50.187 68.764 93.008 90.00 101.46 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019925 0.000000 0.004039 0.00000 SCALE2 0.000000 0.014542 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010970 0.00000 MASTER 336 0 2 16 22 0 8 6 0 0 0 42 END